Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: A multicentric randomized double blind study

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Howell, Amy B ^a   Botto, Henry ^b   Combescure, Christophe ^c   Blanc Potard, Anne Béatrice ^d   Gausa, Lluis ^e   Matsumoto, Tetsuro ^f   Tenke, Peter ^g   Sotto, Albert ^d   Lavigne, Jean Philippe ^d,h  

^a RUTGERS UNIVERSITY   (United States)

^b FOCH HOSPITAL   (France)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d INSERM   (France)

^e FUNDACIÓ PUIGVERT   (Spain)

^f KYUSHU UNIVERSITY   (Japan)

^g Department of Urology   (Hungary)

^h DEPARTMENT OF NEUROLOGY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ELLURA; MANNOSE; PLACEBO; PROANTHOCYANIDIN; UNCLASSIFIED DRUG; URELL; ANTIINFECTIVE AGENT;

ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOASSAY; CAENORHABDITIS ELEGANS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANBERRY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; EPITHELIUM CELL; EX VIVO STUDY; FEMALE; FRANCE; HEMAGGLUTINATION TEST; HUMAN; HUMAN CELL; HUNGARY; IN VIVO STUDY; JAPAN; MORNING DOSAGE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; SPAIN; URINALYSIS; UROPATHOGENIC ESCHERICHIA COLI; VOLUNTEER; ANIMAL; BACTERIUM ADHERENCE; CELL LINE; CHEMISTRY; DRUG EFFECT; ORAL DRUG ADMINISTRATION; POWDER; URINE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; CELL LINE; DOUBLE-BLIND METHOD; FRANCE; HUMANS; HUNGARY; JAPAN; POWDERS; PROANTHOCYANIDINS; SPAIN; URINE; UROPATHOGENIC ESCHERICHIA COLI; VACCINIUM MACROCARPON;

EID: 77950644517     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-94     Document Type: Article

References (29)

1. Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database of Syst Rev 2008, 1:CD001321.
2. Sobota AE. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J Urol 1984, 131:1013-1016.
3. Zafriri D, Ofek I, Adar R, Pocino M, Sharon N. Inhibitory activity of cranberry juice on adherence of type I and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother 1989, 33:92-98. 171427, 2653218.
4. Ofek I, Goldhar J, Zafriri D, Lis H, Adar R, Sharon N. Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. N Engl J Med 1991, 324:1599.
5. Beachey EH. Bacterial adherence: Adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J Infect Dis 1981, 143:325-345.
6. Howell AB, Vorsa N, Der Marderosian A, Foo LY. Inhibition of adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N Engl J Med 1998, 339:1085-1086. 10.1056/NEJM199810083391516, 9767006.
7. Foo LY, Lu Y, Howell AB, Vorsa N. A-type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli . J Nat Prod 2000, 63:1225-1228. 10.1021/np000128u, 11000024.
8. Liu Y, Black MA, Caron L, Camesano TA. Role of cranberry juice on molecular-scale surface characteristics and adhesion behavior of Escherichia coli . Biotechnol Bioeng 2006, 93:297-305. 10.1002/bit.20675, 16142789.
9. Gupta K, Chou MY, Howell A, Wobbe C, Grady R, Stapelton AE. Cranberry products inhibit adherence of uropathogenic Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol 2007, 177:2357-2360. 10.1016/j.juro.2007.01.114, 17509358.
10. Howell AB, Leahy MM, Kurowska E, Guthrie N. In vivo evidence that cranberry proanthocyanidins inhibit adherence of P-fimbriated E. coli bacteria to uroepithelial cells. FASEB J 2001, 15:A284.
11. Howell AB, Reed JD, Krueger CG, Winterbottom R, Cunningham DG, Leahy M. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry 2005, 66:2281-2291. 10.1016/j.phytochem.2005.05.022, 16055161.
12. Lavigne JP, Bourg G, Combescure C, Botto H, Sotto A. In-vitro and in-vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules. Clin Microbiol Infect 2008, 14:350-355. 10.1111/j.1469-0691.2007.01917.x, 18190583.
13. Di Martino P, Agniel R, David K, Templer C, Gaillard JL, Denys P, Botto H. Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebo-controlled cross-over trial. World J Urol 2006, 24:21-27. 10.1007/s00345-005-0045-z, 16397814.
14. Turner A, Chen SN, Joike MK, Pendland SL, Pauli GF, Famsworth NR. Inhibition of uropathogenic Escherichia coli by cranberry juice: A new antiadherence assay. J Agric Food Chem 2005, 53:8940-8947. 10.1021/jf052035u, 16277386.
15. Howell AB, Foxman B. Cranberry juice and adhesion of antibiotic-resistant uropathogens. JAMA 2002, 287:3082-3083. 10.1001/jama.287.23.3082, 12069670.
16. Greenberg JA, Newman SJ, Howell AB. Consumption of sweetened dried cranberries versus unsweetened raisins for inhibition of uropathogenic Escherichia coli in human urine: A pilot study. J Altern Complem Med 2005, 11:875-878.
17. Valentova K, Stejskal D, Bednar P, Vostalova J, Cihalik C, Vecerova R, Koukalova D, Kolar M, Reichenbach R, Sknouril L, Ulrichova J, Simanek V. Biosafety, antioxidant status, and metabolites in urine after consumption of dried cranberry juice in healthy women: A pilot double-blind placebo-controlled trial. J Agric Food Chem 2007, 55:3217-3224. 10.1021/jf0636014, 17381122.
18. Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA. Reduction of bacteriuria and pyruria after ingestion of cranberry juice. JAMA 1994, 271:751-754. 10.1001/jama.271.10.751, 8093138.
19. Howell AB. Cranberry capsule ingestion and bacterial anti-adhesion activity of urine. FASEB J 2006, 20:LB454.
20. Walker EB, Barney DP, Mickelsen JN, Walton RJ, Mickelsen RA. Cranberry concentrate: UTI prophylaxis. J Fam Practice 1997, 45:167-168.
21. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol 2002, 9:1558-1562.
22. Prior RL, Lazarus SA, Cao G, Muccitelli H, Hammerstone JF. Identification of procyanidins and anthocyanins in blueberries and cranberries (Vaccinium spp.) using high-performance liquid chromatography/mass spectrometry. J Agric Food Chem 2001, 49:1270-1276. 10.1021/jf001211q, 11312849.
23. Howell AB. Bioactive compounds in cranberries and their role in prevention of urinary tract infections. Mol Nutr Food Res 2007, 51:732-737. 10.1002/mnfr.200700038, 17487930.
24. Amalric J, Mutin PH, Guerrero G, Ponche A, Sotto A, Lavigne JP. Phosphonate monolayers functionalized by silver thiolate species as antibacterial nanocoatings on titanium and stainless steel. J Mater Chem 2009, 19:141-149.
25. Lavigne JP, Blanc-Potard AB, Blossier G, Moreau J, Chanal C, Bouziges N, O'Callaghan D, Sotto A. Virulence genotype and nematode killing properties of extraintestinal Escherichia coli producing CTX-M β-lactamases. Clin Microbiol Inf 2006, 12:1199-1206.
26. Garsin DA, Sifri CD, Mylonakis E, Qin X, Singh KV, Murray BE, Calderwood SB, Ausubel FM. A simple model host for identifying Gram-positive virulence factors. Proc Natl Acad Sci USA 2001, 98:10892-10897. 10.1073/pnas.191378698, 58570, 11535834.
27. Ohnishi R, Ito H, Kasajima N, Kaneda M, Kariyama R, Kumon H, hatano T, Yoshida T. Urniary excretion of anthocyanins in humans after cranberry juice ingestion. Biosci Biotechnol Biochem 2006, 70:1681-1687. 10.1271/bbb.60023, 16861803.
28. Sifri CD, Begun J, Ausubel FM. The worm has turned--microbial virulence modeled in Caenorhabditis elegans . Trends Microbiol 2005, 13:119-127. 10.1016/j.tim.2005.01.003, 15737730.
29. Diard M, Baeriswyl S, Clermont O, Gouriou S, Picard B, Taddei F, Denamur E, Matic I. Caenorhabditis elegans as a simple model to study phenotypic and genetic virulence determinants of extraintestinal pathogenic Escherichia coli. Microbes Infect 2007, 9:214-223. 10.1016/j.micinf.2006.11.009, 17208486.